<DOC>
	<DOC>NCT01857076</DOC>
	<brief_summary>There will be a randomized clinical trial, non-blind, 3-arm treatment (medical, surgical, gastric bypass and ileal transposition surgery with and sleeve), which will be conducted in a single center - S.B.S. Hospital Sirio LibanÃªs, including 75 research subjects with type 2 diabetes mellitus and obesity class I. In order to compare the effect of weight loss on glycemic control among medical and surgical groups, and after 2 years of follow up, the results of efficacy, safety and maintenance will be compared between the three groups.</brief_summary>
	<brief_title>Surgical Treatment in Diabetic Patients With Grade 1 Obesity</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<criteria>Man or woman with Type 2 diabetes mellitus (DM) aged between 25 and 65 years, with time since diagnosis of diabetes less than 10 years. Grade I obesity (BMI between 3035) Inadequate glycemic control with HbA1c between 7.0 to 9.5% at baseline, in the presence of drug treatment for diabetes in the last year. Reserve pancreatic Cpeptide&gt; 1.0 at baseline. Overweight stable defined as BMI&gt; 30 in the last two years. History ketoacidosis, diabetes mellitus type 1, diabetes followed by pancreatitis. Repetition of measurements (ie, 2 or more within 1 week) fasting plasma glucose(FPG) &gt; 240 mg / dL during the pretreatment. History of Severe Proliferative Diabetic Retinopathy. Autonomic neuropathy. Loss or gain significant weight within the last 12 weeks (range, 5% body weight) Renal insufficiency History of renal disease treated with immunosuppressive therapy, history of dialysis or kidney transplantation. Presence of other renal diseases (eg nephrotic syndrome, glomerulonephritis) Acute myocardial infarction, unstable angina (NYHA class IIIIV), revascularization or stroke within the previous 3 months of the initial visit. Uncontrolled hypertension defined as diastolic blood pressure&gt; 100mm/Hg and diastolic blood pressure&gt; 160mm/Hg at the initial visit. History of Hepatitis B or Hepatitis C. Criteria for Hepatic insufficiency defined as Child B and C liver disease clinically active and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) above 3 times the upper limit of normal. History of prior bariatric surgery. Inflammatory Bowel Disease. History neoplasm within the last 5 years (except for squamous cell carcinoma and basal skin and cervical carcinoma in situ) Clinically important hematologic disorder (symptomatic anemia, bone marrow proliferative disorders, thrombocytopenia, ..) History antibody positive human immunodeficiency virus (HIV) Surgery with general anesthesia within 12 weeks prior to the initial visit or incomplete recovery from prior surgery. History of drug or alcohol abuse within 3 years before the initial visit. Pregnancy or breastfeeding or planning pregnancy in the next two years.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Type 2 Diabetes mellitus</keyword>
	<keyword>Grade I obesity</keyword>
	<keyword>Inadequate glycemic control</keyword>
</DOC>